世界の個別化細胞療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Personalized Cell Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4691
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、個別化細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（造血幹細胞、骨格筋幹細胞、間葉系幹細胞、リンパ球、その他）、用途別市場規模（循環器疾患、神経疾患、炎症性疾患、糖尿病、がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・個別化細胞療法の市場動向
・企業の競争状況、市場シェア
・個別化細胞療法の種類別市場規模と予測2016-2027（造血幹細胞、骨格筋幹細胞、間葉系幹細胞、リンパ球、その他）
・個別化細胞療法の用途別市場規模と予測2016-2027（循環器疾患、神経疾患、炎症性疾患、糖尿病、がん、その他）
・個別化細胞療法の北米市場規模2016-2027（アメリカ、カナダ）
・個別化細胞療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・個別化細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・個別化細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・個別化細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis AG、Vericel Corporation、Bellicum Pharmaceuticals、MolMed SpA、Cytori Therapeutics Inc、Gilead Sciences, Inc、Celgene Corporation、Bluebird Bio、Aurora Biopharma Inc、Saneron CCEL Therapeutics，Inc、Kuur Therapeutics、MediGene AG、Sangamo Therapeutics）
・結論

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease

Market Analysis and Insights: Global Personalized Cell Therapy Market
The global Personalized Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cell Therapy market.

Global Personalized Cell Therapy Scope and Market Size
Personalized Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Cell Type
Hematopoietic Stem Cell
Skeletal Muscle Stem Cell
Mesenchymal Stem Cells
Lymphocytes
Others
By Technique
Platelet Transfusions
Bone Marrow Transplantation
Packed Red Cell Transfusions
Organ Transplantation

Segment by Application
Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics，Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hematopoietic Stem Cell
1.2.3 Skeletal Muscle Stem Cell
1.2.4 Mesenchymal Stem Cells
1.2.5 Lymphocytes
1.2.6 Others
1.3 Market by Application
1.3.1 Global Personalized Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Diseases
1.3.3 Neurological Disorders
1.3.4 Inflammatory Diseases
1.3.5 Diabetes
1.3.6 Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Personalized Cell Therapy Market Perspective (2016-2027)
2.2 Personalized Cell Therapy Growth Trends by Regions
2.2.1 Personalized Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cell Therapy Industry Dynamic
2.3.1 Personalized Cell Therapy Market Trends
2.3.2 Personalized Cell Therapy Market Drivers
2.3.3 Personalized Cell Therapy Market Challenges
2.3.4 Personalized Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Personalized Cell Therapy Players by Revenue
3.1.1 Global Top Personalized Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cell Therapy Revenue
3.4 Global Personalized Cell Therapy Market Concentration Ratio
3.4.1 Global Personalized Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cell Therapy Revenue in 2020
3.5 Personalized Cell Therapy Key Players Head office and Area Served
3.6 Key Players Personalized Cell Therapy Product Solution and Service
3.7 Date of Enter into Personalized Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cell Therapy Breakdown Data by Type
4.1 Global Personalized Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Personalized Cell Therapy Breakdown Data by Application
5.1 Global Personalized Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Personalized Cell Therapy Market Size (2016-2027)
6.2 North America Personalized Cell Therapy Market Size by Type
6.2.1 North America Personalized Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Personalized Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Personalized Cell Therapy Market Size by Type (2016-2027)
6.3 North America Personalized Cell Therapy Market Size by Application
6.3.1 North America Personalized Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Personalized Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Personalized Cell Therapy Market Size by Application (2016-2027)
6.4 North America Personalized Cell Therapy Market Size by Country
6.4.1 North America Personalized Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Personalized Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Personalized Cell Therapy Market Size (2016-2027)
7.2 Europe Personalized Cell Therapy Market Size by Type
7.2.1 Europe Personalized Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Personalized Cell Therapy Market Size by Application
7.3.1 Europe Personalized Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Personalized Cell Therapy Market Size by Country
7.4.1 Europe Personalized Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Personalized Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Personalized Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Personalized Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Personalized Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Personalized Cell Therapy Market Size (2016-2027)
9.2 Latin America Personalized Cell Therapy Market Size by Type
9.2.1 Latin America Personalized Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Personalized Cell Therapy Market Size by Application
9.3.1 Latin America Personalized Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Personalized Cell Therapy Market Size by Country
9.4.1 Latin America Personalized Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Personalized Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Personalized Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Personalized Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Personalized Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Personalized Cell Therapy Introduction
11.1.4 Novartis AG Revenue in Personalized Cell Therapy Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Details
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Personalized Cell Therapy Introduction
11.2.4 Vericel Corporation Revenue in Personalized Cell Therapy Business (2016-2021)
11.2.5 Vericel Corporation Recent Development
11.3 Bellicum Pharmaceuticals
11.3.1 Bellicum Pharmaceuticals Company Details
11.3.2 Bellicum Pharmaceuticals Business Overview
11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Introduction
11.3.4 Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2016-2021)
11.3.5 Bellicum Pharmaceuticals Recent Development
11.4 MolMed SpA
11.4.1 MolMed SpA Company Details
11.4.2 MolMed SpA Business Overview
11.4.3 MolMed SpA Personalized Cell Therapy Introduction
11.4.4 MolMed SpA Revenue in Personalized Cell Therapy Business (2016-2021)
11.4.5 MolMed SpA Recent Development
11.5 Cytori Therapeutics Inc
11.5.1 Cytori Therapeutics Inc Company Details
11.5.2 Cytori Therapeutics Inc Business Overview
11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Introduction
11.5.4 Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2016-2021)
11.5.5 Cytori Therapeutics Inc Recent Development
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Details
11.6.2 Gilead Sciences, Inc Business Overview
11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Introduction
11.6.4 Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2016-2021)
11.6.5 Gilead Sciences, Inc Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Cell Therapy Introduction
11.7.4 Celgene Corporation Revenue in Personalized Cell Therapy Business (2016-2021)
11.7.5 Celgene Corporation Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Personalized Cell Therapy Introduction
11.8.4 Bluebird Bio Revenue in Personalized Cell Therapy Business (2016-2021)
11.8.5 Bluebird Bio Recent Development
11.9 Aurora Biopharma Inc
11.9.1 Aurora Biopharma Inc Company Details
11.9.2 Aurora Biopharma Inc Business Overview
11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Introduction
11.9.4 Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2016-2021)
11.9.5 Aurora Biopharma Inc Recent Development
11.10 Saneron CCEL Therapeutics，Inc
11.10.1 Saneron CCEL Therapeutics，Inc Company Details
11.10.2 Saneron CCEL Therapeutics，Inc Business Overview
11.10.3 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Introduction
11.10.4 Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2016-2021)
11.10.5 Saneron CCEL Therapeutics，Inc Recent Development
11.11 Kuur Therapeutics
11.11.1 Kuur Therapeutics Company Details
11.11.2 Kuur Therapeutics Business Overview
11.11.3 Kuur Therapeutics Personalized Cell Therapy Introduction
11.11.4 Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2016-2021)
11.11.5 Kuur Therapeutics Recent Development
11.12 MediGene AG
11.12.1 MediGene AG Company Details
11.12.2 MediGene AG Business Overview
11.12.3 MediGene AG Personalized Cell Therapy Introduction
11.12.4 MediGene AG Revenue in Personalized Cell Therapy Business (2016-2021)
11.12.5 MediGene AG Recent Development
11.13 Sangamo Therapeutics
11.13.1 Sangamo Therapeutics Company Details
11.13.2 Sangamo Therapeutics Business Overview
11.13.3 Sangamo Therapeutics Personalized Cell Therapy Introduction
11.13.4 Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2016-2021)
11.13.5 Sangamo Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Personalized Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hematopoietic Stem Cell
Table 3. Key Players of Skeletal Muscle Stem Cell
Table 4. Key Players of Mesenchymal Stem Cells
Table 5. Key Players of Lymphocytes
Table 6. Key Players of Others
Table 7. Global Personalized Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Personalized Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Personalized Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Personalized Cell Therapy Market Share by Regions (2016-2021)
Table 11. Global Personalized Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Personalized Cell Therapy Market Share by Regions (2022-2027)
Table 13. Personalized Cell Therapy Market Trends
Table 14. Personalized Cell Therapy Market Drivers
Table 15. Personalized Cell Therapy Market Challenges
Table 16. Personalized Cell Therapy Market Restraints
Table 17. Global Personalized Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Personalized Cell Therapy Market Share by Players (2016-2021)
Table 19. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cell Therapy as of 2020)
Table 20. Ranking of Global Top Personalized Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Personalized Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Personalized Cell Therapy Product Solution and Service
Table 24. Date of Enter into Personalized Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Personalized Cell Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Personalized Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Personalized Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Personalized Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Personalized Cell Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Personalized Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Personalized Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Personalized Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Personalized Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Personalized Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Personalized Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Personalized Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Personalized Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Personalized Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Personalized Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Personalized Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Personalized Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Personalized Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Personalized Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Personalized Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Personalized Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Personalized Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Personalized Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Personalized Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Personalized Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Personalized Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Personalized Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Personalized Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Personalized Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Personalized Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Personalized Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Personalized Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Personalized Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis AG Company Details
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Personalized Cell Therapy Product
Table 67. Novartis AG Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Vericel Corporation Company Details
Table 70. Vericel Corporation Business Overview
Table 71. Vericel Corporation Personalized Cell Therapy Product
Table 72. Vericel Corporation Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 73. Vericel Corporation Recent Development
Table 74. Bellicum Pharmaceuticals Company Details
Table 75. Bellicum Pharmaceuticals Business Overview
Table 76. Bellicum Pharmaceuticals Personalized Cell Therapy Product
Table 77. Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 78. Bellicum Pharmaceuticals Recent Development
Table 79. MolMed SpA Company Details
Table 80. MolMed SpA Business Overview
Table 81. MolMed SpA Personalized Cell Therapy Product
Table 82. MolMed SpA Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 83. MolMed SpA Recent Development
Table 84. Cytori Therapeutics Inc Company Details
Table 85. Cytori Therapeutics Inc Business Overview
Table 86. Cytori Therapeutics Inc Personalized Cell Therapy Product
Table 87. Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 88. Cytori Therapeutics Inc Recent Development
Table 89. Gilead Sciences, Inc Company Details
Table 90. Gilead Sciences, Inc Business Overview
Table 91. Gilead Sciences, Inc Personalized Cell Therapy Product
Table 92. Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 93. Gilead Sciences, Inc Recent Development
Table 94. Celgene Corporation Company Details
Table 95. Celgene Corporation Business Overview
Table 96. Celgene Corporation Personalized Cell Therapy Product
Table 97. Celgene Corporation Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 98. Celgene Corporation Recent Development
Table 99. Bluebird Bio Company Details
Table 100. Bluebird Bio Business Overview
Table 101. Bluebird Bio Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 102. Bluebird Bio Recent Development
Table 103. Aurora Biopharma Inc Company Details
Table 104. Aurora Biopharma Inc Business Overview
Table 105. Aurora Biopharma Inc Personalized Cell Therapy Product
Table 106. Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 107. Aurora Biopharma Inc Recent Development
Table 108. Saneron CCEL Therapeutics，Inc Company Details
Table 109. Saneron CCEL Therapeutics，Inc Business Overview
Table 110. Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Product
Table 111. Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 112. Saneron CCEL Therapeutics，Inc Recent Development
Table 113. Kuur Therapeutics Company Details
Table 114. Kuur Therapeutics Business Overview
Table 115. Kuur Therapeutics Personalized Cell Therapy Product
Table 116. Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 117. Kuur Therapeutics Recent Development
Table 118. MediGene AG Company Details
Table 119. MediGene AG Business Overview
Table 120. MediGene AG Personalized Cell Therapy Product
Table 121. MediGene AG Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 122. MediGene AG Recent Development
Table 123. Sangamo Therapeutics Company Details
Table 124. Sangamo Therapeutics Business Overview
Table 125. Sangamo Therapeutics Personalized Cell Therapy Product
Table 126. Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2016-2021) & (US$ Million)
Table 127. Sangamo Therapeutics Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Hematopoietic Stem Cell Features
Figure 3. Skeletal Muscle Stem Cell Features
Figure 4. Mesenchymal Stem Cells Features
Figure 5. Lymphocytes Features
Figure 6. Others Features
Figure 7. Global Personalized Cell Therapy Market Share by Application: 2020 VS 2027
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Inflammatory Diseases Case Studies
Figure 11. Diabetes Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Cell Therapy Report Years Considered
Figure 15. Global Personalized Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Personalized Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Personalized Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 18. Global Personalized Cell Therapy Market Share by Regions (2022-2027)
Figure 19. Global Personalized Cell Therapy Market Share by Players in 2020
Figure 20. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cell Therapy as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Personalized Cell Therapy Revenue in 2020
Figure 22. Global Personalized Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 23. Global Personalized Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 24. North America Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Personalized Cell Therapy Market Share by Type (2016-2027)
Figure 26. North America Personalized Cell Therapy Market Share by Application (2016-2027)
Figure 27. North America Personalized Cell Therapy Market Share by Country (2016-2027)
Figure 28. United States Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Personalized Cell Therapy Market Share by Type (2016-2027)
Figure 32. Europe Personalized Cell Therapy Market Share by Application (2016-2027)
Figure 33. Europe Personalized Cell Therapy Market Share by Country (2016-2027)
Figure 34. Germany Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Personalized Cell Therapy Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Personalized Cell Therapy Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Personalized Cell Therapy Market Share by Region (2016-2027)
Figure 44. China Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Personalized Cell Therapy Market Share by Type (2016-2027)
Figure 52. Latin America Personalized Cell Therapy Market Share by Application (2016-2027)
Figure 53. Latin America Personalized Cell Therapy Market Share by Country (2016-2027)
Figure 54. Mexico Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Personalized Cell Therapy Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Personalized Cell Therapy Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Personalized Cell Therapy Market Share by Country (2016-2027)
Figure 60. Turkey Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Personalized Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Novartis AG Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 64. Vericel Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 65. Bellicum Pharmaceuticals Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 66. MolMed SpA Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 67. Cytori Therapeutics Inc Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 68. Gilead Sciences, Inc Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 69. Celgene Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 70. Bluebird Bio Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 71. Aurora Biopharma Inc Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 72. Saneron CCEL Therapeutics，Inc Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 73. Kuur Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 74. MediGene AG Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 75. Sangamo Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界のT細胞療法市場規模・現状・予測（2021年-2027年）

Global T-Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4937 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、T細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要地域別市場規模（北米、アメ...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3781 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要...

世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年）

Global Placental Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5306 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、胎盤幹細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液悪性腫瘍・障害、先天性免疫不全障害、代謝障害、神経障害、その他）、用途別市場規模（病院・専門クリニック、臨床研究機関、研究機関・学術、...

世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3985 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO...

世界の細胞治療＆組織工学市場規模・現状・予測（2021年-2027年）

Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2021-2027
QFJ1-5122 2021年6月 129Pages
QYResearch社発行の本調査レポートでは、細胞治療＆組織工学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細胞治療、組織工学）、用途別市場規模（細胞欠陥、遺伝病、神経変性疾患、組織悪性腫瘍、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のマントル細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mantle Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5839 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、マントル細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の細胞治療処理市場規模・現状・予測（2021年-2027年）

Global Cell therapy Processing Market Size, Status and Forecast 2021-2027
QFJ1-3368 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、細胞治療処理の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（製品、サービス、ソフトウェア）、用途別市場規模（心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患）、主要地域別市場規模（北米、アメリカ、欧州...

世界の個別化がんワクチン市場規模・現状・予測（2021年-2027年）

Global Personalized Cancer Vaccines Market Size, Status and Forecast 2021-2027
QFJ1-4690 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、個別化がんワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、白血病、前立腺がん、子宮頸がん、神経膠芽細胞腫、その他）、用途別市場規模（病院、在宅医療、専門クリニック...

世界の免疫細胞療法市場規模・現状・予測（2021年-2027年）

Global Immuno-Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4351 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、免疫細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（受動免疫（NK、LAKなど）、能動免疫）、用途別市場規模（腫瘍学、心血管疾患（CVD）、整形外科、創傷治癒、その他）、主要地域別市場規模（北...

世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年） Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regene…
世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の自家幹細胞＆非幹細胞系治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market The global Autologous Stem Cell and Non-Stem Cell Based Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
世界のヒト間葉系幹細胞 (hMSC)市場規模・現状・予測（2021年-2027年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
世界の幹細胞特性評価＆解析ツール市場規模・現状・予測（2021年-2027年） Stem cell characterization is the study of tissue-specific differentiation. There are various type of stem cell such as embryonic stem cell, epithelial stem cell and others. Further, various techniques are used to characterized stem cells such as immunological techniques, used for depiction of diffe…